Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 5.91
-9.91 %
$ 315 M
Market Cap
-7.88
P/E
CASH FLOW STATEMENT
-18.9 M
OPERATING CASH FLOW
-7.74 M
INVESTING CASH FLOW
12.8 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Alpha Teknova, Inc.
| Net Income | -36.8 M |
| Depreciation & Amortization | 5.66 M |
| Capital Expenditures | -7.93 M |
| Stock-Based Compensation | 4.14 M |
| Change in Working Capital | 2.25 M |
| Others | 8.6 M |
| Free Cash Flow | -26.7 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||
| Net Income | (36.8) | (47.5) | (9.8) | 3.6 | (1.3) |
| Depreciation & Amortization | 5.7 | 3.2 | 2.9 | 2.0 | 1.6 |
| Deferred Income Tax | (0.3) | (1.9) | (2.8) | 2.1 | (0.5) |
| Stock Based Compensation | 4.1 | 3.7 | 1.6 | 0.3 | 75 K |
| Other Operating Activities | 6.2 | 22.5 | 0.8 | 7 K | 63 K |
| Change in Working Capital | 2.2 | (7.3) | (1.7) | (5.5) | 2.3 |
| Cash From Operations | (18.8) | (27.4) | (9.1) | 2.5 | 2.2 |
| INVESTING CASH FLOW | |||||
| Capital Expenditures | (7.9) | (28.1) | (19.9) | (5.5) | (2.6) |
| Other Items | 0.2 | 0 | 2.4 | 3.7 | (5.5) |
| Cash From Investing Activities | (7.7) | (28.1) | (17.5) | (1.7) | (8.2) |
| FINANCING CASH FLOW | |||||
| Common Stock Repurchased | 0 | 0.3 | 0 | 0 | (19.5) |
| Total Debt Repaid | (10.0) | 10.1 | 11.9 | 45 K | (0.8) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 22.8 | 0.1 | (3.8) | (1.6) | 71.5 |
| Cash From Financing Activities | 12.8 | 10.3 | 110.8 | (1.6) | 8.6 |
| CHANGE IN CASH | |||||
| Net Change In Cash | (13.8) | (45.3) | 84.2 | (0.8) | 2.6 |
| FREE CASH FLOW | |||||
| Free Cash Flow | (26.7) | (55.5) | (28.9) | (3.0) | (0.5) |